354 related articles for article (PubMed ID: 10416607)
1. Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish CR; Freeman C; Brown KJ; Francis DJ; Cowden WB
Cancer Res; 1999 Jul; 59(14):3433-41. PubMed ID: 10416607
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
3. Oligomannurarate sulfate, a novel heparanase inhibitor simultaneously targeting basic fibroblast growth factor, combats tumor angiogenesis and metastasis.
Zhao H; Liu H; Chen Y; Xin X; Li J; Hou Y; Zhang Z; Zhang X; Xie C; Geng M; Ding J
Cancer Res; 2006 Sep; 66(17):8779-87. PubMed ID: 16951194
[TBL] [Abstract][Full Text] [Related]
4. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin.
Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R
Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578
[TBL] [Abstract][Full Text] [Related]
5. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
[TBL] [Abstract][Full Text] [Related]
6. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis.
Ferro V; Dredge K; Liu L; Hammond E; Bytheway I; Li C; Johnstone K; Karoli T; Davis K; Copeman E; Gautam A
Semin Thromb Hemost; 2007 Jul; 33(5):557-68. PubMed ID: 17629854
[TBL] [Abstract][Full Text] [Related]
7. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological evaluation of polysulfated oligosaccharide glycosides as inhibitors of angiogenesis and tumor growth.
Johnstone KD; Karoli T; Liu L; Dredge K; Copeman E; Li CP; Davis K; Hammond E; Bytheway I; Kostewicz E; Chiu FC; Shackleford DM; Charman SA; Charman WN; Harenberg J; Gonda TJ; Ferro V
J Med Chem; 2010 Feb; 53(4):1686-99. PubMed ID: 20128596
[TBL] [Abstract][Full Text] [Related]
9. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
10. Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis.
Ilan N; Elkin M; Vlodavsky I
Int J Biochem Cell Biol; 2006; 38(12):2018-39. PubMed ID: 16901744
[TBL] [Abstract][Full Text] [Related]
11. An antiangiogenic urokinase-derived peptide combined with tamoxifen decreases tumor growth and metastasis in a syngeneic model of breast cancer.
Guo Y; Mazar AP; Lebrun JJ; Rabbani SA
Cancer Res; 2002 Aug; 62(16):4678-84. PubMed ID: 12183425
[TBL] [Abstract][Full Text] [Related]
12. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
13. [Research advancement on heparanase in tumor metastasis].
Li ZH; Yang SM
Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
[TBL] [Abstract][Full Text] [Related]
14. A phase I biological and pharmacologic study of the heparanase inhibitor PI-88 in patients with advanced solid tumors.
Basche M; Gustafson DL; Holden SN; O'Bryant CL; Gore L; Witta S; Schultz MK; Morrow M; Levin A; Creese BR; Kangas M; Roberts K; Nguyen T; Davis K; Addison RS; Moore JC; Eckhardt SG
Clin Cancer Res; 2006 Sep; 12(18):5471-80. PubMed ID: 17000682
[TBL] [Abstract][Full Text] [Related]
15. Mammalian heparanase: involvement in cancer metastasis, angiogenesis and normal development.
Vlodavsky I; Goldshmidt O; Zcharia E; Atzmon R; Rangini-Guatta Z; Elkin M; Peretz T; Friedmann Y
Semin Cancer Biol; 2002 Apr; 12(2):121-9. PubMed ID: 12027584
[TBL] [Abstract][Full Text] [Related]
16. Oligosaccharides from fucosylated glycosaminoglycan prevent breast cancer metastasis in mice by inhibiting heparanase activity and angiogenesis.
Zhou L; Yin R; Gao N; Sun H; Chen D; Cai Y; Ren L; Yang L; Zuo Z; Zhang H; Zhao J
Pharmacol Res; 2021 Apr; 166():105527. PubMed ID: 33667689
[TBL] [Abstract][Full Text] [Related]
17. PI-88 and Related Heparan Sulfate Mimetics.
Chhabra M; Ferro V
Adv Exp Med Biol; 2020; 1221():473-491. PubMed ID: 32274723
[TBL] [Abstract][Full Text] [Related]
18. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
[TBL] [Abstract][Full Text] [Related]
19. [Human heparanase: roles in invasion and metastasis of cancer].
Gohji K; Katsuoka Y; Okamoto M; Kamidono S; Kitazawa S; Toyoshima M; Dong J; Nakajima M
Hinyokika Kiyo; 2000 Oct; 46(10):757-62. PubMed ID: 11215206
[TBL] [Abstract][Full Text] [Related]
20. Heparanase, heparin and the coagulation system in cancer progression.
Vlodavsky I; Ilan N; Nadir Y; Brenner B; Katz BZ; Naggi A; Torri G; Casu B; Sasisekharan R
Thromb Res; 2007; 120 Suppl 2():S112-20. PubMed ID: 18023704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]